Oxysterol Nanoparticles Targeting LDL Receptors for Cancer Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer treatments lack effective targeting mechanisms for cancer cells with high LDL receptor expression, and there is a need for alternative therapies that can exert cytotoxic effects on these cells while delivering therapeutic agents.
Innovation Solution
The development of oxysterol-based lipoprotein-like particles that self-assemble to target cancer cells with high LDL receptor expression, exerting cytotoxic effects and enhancing the delivery of cancer therapeutics by binding to these cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cholesterol microemulsions are used to deliver chemotherapeutic agents to cancer cells, then delivery of therapeutic agents is improved, but lack of cytotoxic effect and insufficient targeting capability worsens treatment efficacy
Solution Approach 1:
The patent combines cholesterol microemulsion delivery system with oxysterol cytotoxic agent into a single integrated therapy. The microemulsion delivers both chemotherapeutic agents and oxysterols to cancer cells, merging the benefits of targeted delivery with direct cytotoxic action to overcome the insufficiency of delivery-only systems
Solution Approach 2:
The invention uses composite lipoprotein-like particles containing both cholesterol and oxysterols. This composite structure allows the system to function both as a delivery vehicle (cholesterol component) and as a cytotoxic agent (oxysterol component), simultaneously addressing delivery and treatment efficacy
2Productivity
If conventional chemotherapeutic agents are used, then broad cancer cell killing is achieved, but lack of selectivity for high LDL receptor expressing cells worsens side effects on normal cells
Solution Approach 1:
The patent applies local quality by making the therapeutic system selectively active only at the target site. Oxysterols are delivered specifically to cells with high LDL receptor expression through receptor-mediated endocytosis, ensuring cytotoxic action is localized to cancer cells while sparing normal cells with lower receptor expression
Solution Approach 2:
The invention exploits parameter changes in cancer cells (upregulated LDL receptor expression) to achieve selective targeting. The system's ability to bind and enter cells depends on the density of LDL receptors, creating a parameter-based selection mechanism that distinguishes cancer cells from normal cells
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The oxysterol particles demonstrate a synergistic effect with cancer therapeutics, preferentially targeting and killing cancer cells with high LDL receptor expression, while minimizing impact on normal cells, thus offering a novel approach to cancer treatment.
Implementation Method 1
The development of oxysterol-based lipoprotein-like particles that self-assemble to target cancer cells with high LDL receptor expression
Data Source
AI summary
An oxysterol or oxysterol-like compound is provided, which finds use in treating and/or targeting cancer.